Donald Trump's commerce secretary nominee told his US Senate confirmation hearing Wednesday he favors "across-the-board" tariffs targeting countries rather than products, while signaling a hawkish ...

Cantor Fitzgerald initiated coverage of Acrivon Therapeutics (ACRV) with an Overweight rating without a price target The company has two ...

In a recent industry report focused on Biotechnology stocks, particularly those innovating in neurology and psychiatry, ...

Cantor Fitzgerald has a convertible bond with Tether, incoming Commerce Secretary Howard Lutnick said at his confirmation hearing, confirming previous reporting by The Wall Street Journal that ...

Cantor Fitzgerald upgraded Lam Research (LRCX) to Overweight from Neutral with a price target of $100, up from $95. The firm had suggested ...

Fintel reports that on January 29, 2025, Cantor Fitzgerald upgraded their outlook for Beam Therapeutics (NasdaqGS:BEAM) from ...

Cantor Fitzgerald currently has a “Overweight” rating and a $6.00 price target on the stock. The consensus estimate for VinFast Auto’s current full-year earnings is ($1.03) per share. Get ...

This month, Flagstar offloaded $142 million of that portfolio, finding a buyer in Howard Lutnick’s Cantor Fitzgerald, PincusCo reported. A spokesperson for Cantor Fitzgerald did not return a ...

Cantor Fitzgerald currently has a “Overweight” rating and a $160.00 target price on the stock. The consensus estimate for Novo Nordisk A/S’s current full-year earnings is $3.13 per share.

In preparation for the launch, Cantor Fitzgerald hosted a discussion with a Senior Director of Product Development at UnitedHealth (NYSE:UNH). The conversation provided insights into the coverage ...

On Monday, analysts at Cantor Fitzgerald reaffirmed their Overweight rating on Western Digital Corp. (NASDAQ:WDC) shares, with a steady price target of $95.00. According to InvestingPro data ...